Prostate Cancer - Results from #26620

20 Gy versus 44 Gy of supplemental external beam radiotherapy with palledium-103 for patients with greater risk disease: Results of a prospective randomized trial - Abstract January 24, 2012

Risk factors and quality of life for post-prostatectomy vesicourethral anastomotic stenoses - Abstract January 24, 2012

Measurement of PSA density by 3 imaging modalities and its correlation with the PSA density of radical prostatectomy specimen - Abstract January 24, 2012

Comparison of prostate volume, shape, and contouring variability determined from preimplant magnetic resonance and transrectal ultrasound images - Abstract January 24, 2012

High-dose-rate brachytherapy as monotherapy delivered in two fractions within one day for favorable/intermediate-risk prostate cancer: Preliminary toxicity data - Abstract January 24, 2012

Prostate cancer study proves drug delays disease progression January 24, 2012

Eating smart: Researcher studies foods, dietary supplements that may reduce risk of prostate cancer January 24, 2012

Usefulness and predictive value of PSA density, adjusted by transition zone volume, in men with PSA levels between 2 and 4 ng/ml - Abstract January 23, 2012

Optimising repeat prostate biopsy decisions and procedures - Abstract January 23, 2012

Quantitative tissue analyses of prostate cancer foci in an unselected cystoprostatectomy series - Abstract January 23, 2012

Comparative effectiveness of cryotherapy vs brachytherapy for localised prostate cancer - Abstract January 23, 2012

Obstructive uropathy from locally advanced and metastatic prostate cancer: An old problem with new therapies - Abstract January 23, 2012

Environment as a potential key determinant of the continued increase of prostate cancer incidence in martinique - Abstract January 23, 2012

Controversy over treatment options in clinical T3 prostate cancer - Abstract January 23, 2012

Prostatectomy-pros and cons on open surgery/laparoscopic surgery/robot-assisted surgery - Abstract January 23, 2012

Castration-resistant prostate cancer: Where are we going? - Abstract January 23, 2012

A comparison of the impact of isotope ((125)I vs. (103)Pd) on toxicity and biochemical outcome after interstitial brachytherapy and external beam radiation therapy for clinically localized prostate cancer - Abstract January 23, 2012

Usefulness and predictive value of PSA density, adjusted by transition zone volume, in men with PSA levels between 2 and 4 ng/ml - Abstract January 23, 2012

NutriTRAILomics in prostate cancer: Time to have two strings to one's bow - Abstract January 23, 2012

Comparative analysis of three risk assessment tools in Australian patients with prostate cancer - Abstract January 20, 2012

Page 1332 of 1445